Cargando…
Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis
Despite the introduction of biologics, topical dithranol (anthralin) has remained one of the most effective anti-psoriatic agents. Serial biopsies from human psoriatic lesions and both the c-Jun/JunB and imiquimod psoriasis mouse model allowed us to study the therapeutic mechanism of this drug. Top...
Autores principales: | Benezeder, Theresa, Painsi, Clemens, Patra, VijayKumar, Dey, Saptaswa, Holcmann, Martin, Lange-Asschenfeldt, Bernhard, Sibilia, Maria, Wolf, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266641/ https://www.ncbi.nlm.nih.gov/pubmed/32484435 http://dx.doi.org/10.7554/eLife.56991 |
Ejemplares similares
-
Induction of IL‐1β and antimicrobial peptides as a potential mechanism for topical dithranol
por: Benezeder, Theresa, et al.
Publicado: (2021) -
Furin Expression in Patients With Psoriasis—A Patient Cohort Endangered to SARS-COV2?
por: Graier, Thomas, et al.
Publicado: (2021) -
Crosstalk: keratinocytes and immune cells in psoriasis
por: Kamata, Masahiro, et al.
Publicado: (2023) -
Dendrimer entrapped microsponge gel of dithranol for effective topical treatment
por: Tripathi, Pushpendra Kumar, et al.
Publicado: (2019) -
Dithranol as novel co-adjuvant for non-invasive dermal vaccination
por: Sohl, Julian, et al.
Publicado: (2022)